Is Otsuka a real company?
Otsuka is a completely legitimate, fully operational multinational corporate conglomerate with a rich business history spanning decades. It encompasses multiple specialized subsidiaries operating across pharmaceuticals, medical devices, and consumer nutrition products, servicing millions of customers and patients globally. Its official corporate registries, physical manufacturing plants, and transparent public market listings confirm its absolute authenticity.
Related FAQs
Otsuka Holdings Co., Ltd. trades publicly on the Tokyo Stock Exchange under the ticker symbol 4578, allowing institutional and retail investors to purchase equity shares in the enterprise.
Otter Tail Corporation (trading under the ticker OTTR) distributes regular quarterly cash dividend payments to its eligible equity investors, backed by an impressive multi-decade track record of consecutive annual dividend increases.
Design engineers, process control specialists, and product development engineers employed by Sensata Technologies earn competitive professional salaries that reflect expertise in industrial sensors, electrical protection components, and aerospace ...
Otsuka Holdings Co., Ltd.
Otsuka is generally regarded as a reputable, research-driven healthcare and pharmaceutical enterprise committed to developing innovative therapeutic solutions for complex medical conditions.
Japan's pharmaceutical and healthcare sector features major global enterprises renowned for innovative drug discovery, advanced chemistry, and international clinical research.
The major global pharmaceutical and corporate enterprise Otsuka Pharmaceutical Co., Ltd. maintains its primary corporate headquarters and administrative base in Tokyo, Japan, with additional major executive offices located in Osaka.
In the Japanese language, the traditional family surname and geographic proper noun Otsuka (written in kanji as 大塚) is a compound word formed from o, meaning "large" or "great," and tsuka, meaning "hill," "mound," or "tumulus.